Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22IgA%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22IgA%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22IgA%22&type=Subject
PubPharm (486)
1
A study to assess if two different doses of Nefecon taken as capsules are safe and effective in patients with primary IgA nephropathy at risk of developing end-stage renal disease : A Multicentre, Interventional Treatment, Randomised, Double-Blind, Single Group Assignment, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of Nefecon® in Primary IgA Nephropathy Patients at Risk of Developing End-Stage Renal Disease - The NEFIGAN Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Testing the Safety and Activity of Sparsentan in the Treatment of Patients with IgA Nephropathy : A Single Centre, Open-label, Single-group Exploratory Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients with Immunoglobulin A Nephropathy - SPARTAN v1.0
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to assess if two different doses of Nefecon taken as capsules are safe and effective in patients with primary IgA nephropathy at risk of developing end-stage renal disease : A Multicentre, Interventional Treatment, Randomised, Double-Blind, Single Group Assignment, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of Nefecon® in Primary IgA Nephropathy Patients at Risk of Developing End-Stage Renal Disease - The NEFIGAN Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Testing the Safety and Activity of Sparsentan in the Treatment of Patients with IgA Nephropathy : A Single Centre, Open-label, Single-group Exploratory Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients with Immunoglobulin A Nephropathy - SPARTAN v1.0
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and contacts : The Prevalence of persistent viral shedding and antibody levels among recovered COVID-19 patients of the hospitals and Public Health Centers under Bangkok Metropolitan Administration
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Clinicopathological and outcome analysis of IgA Nephropathy patients : Clinicopathological and outcome analysis of IgA Nephropathy patients in China
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Effect of Lactobacillus Plantarum IS-10506 supplementation on systemic and humoral mucosal immune responses in children with HIV infection with antiretroviral therapy : Effect of Lactobacillus Plantarum IS-10506 supplementation on systemic and humoral mucosal immune responses in children with HIV infection with antiretroviral therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II : Systemic ozone therapy by means rectal insuflaction applied of the patiens with inmunoglobulin A deficency. (OTIGAD-2) - OTIGAD-2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Effect of Astragalus membranaceus on Cosmc expression and IgA dys-glycosylation in IgA Nephropathy : Effect of Astragalus membranaceus on Cosmc expression and IgA dys-glycosylation in IgA Nephropathy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[49]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
486
Aufsätze
486
E-Artikel
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
486
610
410
Study Type: Interventional
180
Recruitment Status: Authorised-recruitment may ...
138
Recruitment Status: Not yet recruiting
122
Phase: Phase 3
110
Medical Condition: IgA nephropathy
106
Phase: Phase 2
78
Recruitment Status: Recruiting
56
Study Type: Observational
46
Recruitment Status: Completed
38
Medical Condition: IgA Nephropathy MedDRA versi...
34
Medical Condition: IgA Nephropathy
32
Medical Condition: Primary IgA nephropathy pati...
26
Recruitment Status: Complete: follow-up complete
22
Medical Condition: Immunoglobulin A Nephropathy...
22
Medical Condition: Primary IgA Nephropathy MedD...
22
Phase: Other
18
Phase: Post-market
14
Medical Condition: Primary IgA nephropathy pati...
14
Phase: Retrospective study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
362
2020-
124
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
468
Englisch
14
Unbestimmt
2
Französisch
2
Spanisch
Haven't found what you're looking for?
Wird geladen...